Works matching AU Park, Sung-Hye

Results: 180
    1
    2
    3
    4
    5

    Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD.

    Published in:
    Annals of Clinical & Translational Neurology, 2025, v. 12, n. 4, p. 861, doi. 10.1002/acn3.52301
    By:
    • Kwon, Young Nam;
    • Tisavipat, Nanthaya;
    • Guo, Yong;
    • Syc‐Mazurek, Stephanie B.;
    • Han, Ji Yeon;
    • Kim, Jun‐Soon;
    • Choi, Kyomin;
    • Oh, Seong‐il;
    • Choi, Seok‐Jin;
    • Sohn, Eunhee;
    • Oh, Jeeyoung;
    • Kim, Seung Woo;
    • Shin, Ha Young;
    • Lim, Byung Chan;
    • Kim, Byoung Joon;
    • Park, Kyung Seok;
    • Sung, Jung‐Joon;
    • Kim, Se Hoon;
    • Park, Sung‐Hye;
    • Zekeridou, Anastasia
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    SNUH methylation classifier for CNS tumors.

    Published in:
    Clinical Epigenetics, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13148-025-01824-0
    By:
    • Lee, Kwanghoon;
    • Jeon, Jaemin;
    • Park, Jin Woo;
    • Yu, Suwan;
    • Won, Jae-Kyung;
    • Kim, Kwangsoo;
    • Park, Chul-Kee;
    • Park, Sung-Hye
    Publication type:
    Article
    13
    14
    15

    cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading.

    Published in:
    Brain Pathology, 2020, v. 30, n. 4, p. 844, doi. 10.1111/bpa.12832
    By:
    • Louis, David N.;
    • Wesseling, Pieter;
    • Aldape, Kenneth;
    • Brat, Daniel J.;
    • Capper, David;
    • Cree, Ian A.;
    • Eberhart, Charles;
    • Figarella‐Branger, Dominique;
    • Fouladi, Maryam;
    • Fuller, Gregory N.;
    • Giannini, Caterina;
    • Haberler, Christine;
    • Hawkins, Cynthia;
    • Komori, Takashi;
    • Kros, Johan M.;
    • Ng, HK;
    • Orr, Brent A.;
    • Park, Sung‐Hye;
    • Paulus, Werner;
    • Perry, Arie
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 7, p. 1995, doi. 10.1007/s00262-020-02836-w
    By:
    • Kim, A. Reum;
    • Choi, Kyu Sung;
    • Kim, Min-Sung;
    • Kim, Kyung-Min;
    • Kang, Ho;
    • Kim, Sojin;
    • Chowdhury, Tamrin;
    • Yu, Hyeon Jong;
    • Lee, Chae Eun;
    • Lee, Joo Ho;
    • Lee, Soon-Tae;
    • Won, Jae Kyung;
    • Kim, Jin Wook;
    • Kim, Yong-Hwy;
    • Kim, Tae Min;
    • Park, Sung-Hye;
    • Choi, Seung Hong;
    • Shin, Eui-Cheol;
    • Park, Chul-Kee
    Publication type:
    Article
    22

    Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.

    Published in:
    Acta Neuropathologica, 2014, v. 128, n. 1, p. 111, doi. 10.1007/s00401-014-1285-z
    By:
    • Kock, Leanne;
    • Sabbaghian, Nelly;
    • Plourde, François;
    • Srivastava, Archana;
    • Weber, Evan;
    • Bouron-Dal Soglio, Dorothée;
    • Hamel, Nancy;
    • Choi, Joon;
    • Park, Sung-Hye;
    • Deal, Cheri;
    • Kelsey, Megan;
    • Dishop, Megan;
    • Esbenshade, Adam;
    • Kuttesch, John;
    • Jacques, Thomas;
    • Perry, Arie;
    • Leichter, Heinz;
    • Maeder, Philippe;
    • Brundler, Marie-Anne;
    • Warner, Justin
    Publication type:
    Article
    23
    24
    25
    26
    27

    Perspective of mesenchymal transformation in glioblastoma.

    Published in:
    Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01151-4
    By:
    • Kim, Yona;
    • Varn, Frederick S.;
    • Park, Sung-Hye;
    • Yoon, Byung Woo;
    • Park, Hye Ran;
    • Lee, Charles;
    • Verhaak, Roel G. W.;
    • Paek, Sun Ha
    Publication type:
    Article
    28
    29
    30
    31

    Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging.

    Published in:
    PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113587
    By:
    • Kim, Jae Hyun;
    • Choi, Seung Hong;
    • Ryoo, Inseon;
    • Yun, Tae Jin;
    • Kim, Tae Min;
    • Lee, Se-Hoon;
    • Park, Chul-Kee;
    • Kim, Ji-Hoon;
    • Sohn, Chul-Ho;
    • Park, Sung-Hye;
    • Kim, Il Han
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.

    Published in:
    2016
    By:
    • Sehui Kim;
    • Soo Jeong Nam;
    • Dohee Kwon;
    • Hannah Kim;
    • Eunyoung Lee;
    • Tae Min Kim;
    • Dae Seog Heo;
    • Sung Hye Park;
    • Chul Woo Kim;
    • Yoon Kyung Jeon;
    • Kim, Sehui;
    • Nam, Soo Jeong;
    • Kwon, Dohee;
    • Kim, Hannah;
    • Lee, Eunyoung;
    • Kim, Tae Min;
    • Heo, Dae Seog;
    • Park, Sung Hye;
    • Kim, Chul Woo;
    • Jeon, Yoon Kyung
    Publication type:
    journal article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50